期刊文献+

胆碱-蛋氨酸缺乏饲料诱导的非酒精性脂肪肝大鼠chemerin及其受体的表达 被引量:1

The expression of chemerin and chemerin receptor in rats with methionine-and choline-deficient diet induced nonalcoholic fatty liver disease
原文传递
导出
摘要 目的 探讨胆碱.蛋氨酸缺乏饲料(MCD)诱导非酒精性脂肪性肝病(nonalcoholic fatty liver disease,NAFLD)不同时期大鼠肝脏chemerin及其受体(chemokine-like receptor 1,CMKLRI)表达的动态变化.方法 Wistar大鼠随机分为对照组和MCD组.适应性喂养1周后,分别给予普通饲料和MCD饲料喂养,分别在喂养1、4、10周时处死.检测血清谷丙转氨酶(alanine transarninase,ALT)、血脂、肝功能及肝脏TG含量,并做HE染色观察肝脏形态变化;采用实时荧光定量PCR检测细胞因子chemerin及CMKLR1 mRNA水平的表达变化,并用Northern印迹进一步确认chemerin mRNA水平的表达变化.Western印迹检测小鼠血清chemerin水平.结果 MCD饲料喂养1、4和10周后,MCD组肝脏chemerin的mRNA表达逐渐下降(1.00±0.08对0.72±0.10;1.00±0.24对0.63±0.31;1.00±0.05对0.50±0.13);CMKLR1表达逐渐上升(1.00±0.14对0.84±0.26;1.00±0.38对1.51±0.33;1.01±0.13对1.84±0.39).血清chemerin含量减少(1.00±0.11对0.96±0.39;1.00±0.12对0.21±0.77;1.00±0.42对0.21±0.11).结论 Chemerin及其受体的表达变化可能参与了MCD饲料诱导的非酒精性脂肪肝的发病过程. Objective To explore the expression of chemerin and chemerin receptor ( chemokine-like receptor 1, CMKLR1) during different periods of non-alcoholic fatty liver disease ( NAFLD) rat model induced by methionine- and choline-deficient ( MCD) diet. Methods Thirty-six Wistar rats were divided into control group and MCD group in random. After one week quarantine and acclimation period, these two groups were fed either normal chow or MCD diet. The animals were respectively sacrificed at the first week, the forth week, and the tenth week. The levels of alanine transaminase (ALT), blood lipid profile, liver function, and the content of triglyceride in liver were detected. HE staining was done to observe the morphologic change of liver. The mRNA expression changes of chemerin and CMKLR1 in liver were measured using real-time PCR, and the change in chemerin mRNA level was further confirmed in liver by Northern blot. Finally, the concentration of chemerin in serum was measured by Western blot. Results The mRNA level of chemerin decreased significantly after four and ten weeks MCD feeding, although no obvious changes were found at first week, similar changes were found in serum chemerin (1.00±0.11 vs 0.96±0.39; 1.00±0.12 vs 0.21 ±0.77; 1.00±0.42 vs 0.21 ±0. 11). Contrasting with the change of chemerin(1.00±0.08 vs 0.72±0.10;1.00±0.24 vs 0.63±0. 31 ;1.00±0.05 vs 0.50±0.13), the mRNA level of CMKLR1 increased after MCD feeding( 1.00±0. 14 vs 0. 84±0. 26; 1.00±0. 38 vs 1. 51 ±0. 33; 1. 01 ±0. 13 vs 1. 84 ± 0. 39 ). Conclusion The change of chemerin and its receptor may participate in the process of the nonalcoholic fatty liver disease.
出处 《中华内分泌代谢杂志》 CAS CSCD 北大核心 2010年第7期550-554,共5页 Chinese Journal of Endocrinology and Metabolism
基金 国家自然科学基金资助项目(30771020)
关键词 胆碱-蛋氨酸缺乏饲料 趋化素 趋化因子样受体-1 非酒精性脂肪肝 Methionine- and choline-deficient diet Chemerin CMKLR1 Nonalcoholic fatty liver disease
  • 相关文献

参考文献14

  • 1Wittamer,V,Franssen JD,Vulcano M,et al.Specific recruitment of antigen-presenting cells by chemerin,a novel processed ligand from human innammatory fluids.J Exp Med,2003,198:977-985.
  • 2Coralski KB,McCarthy TC,Hanniman EA,et al.Chemerin,a novel adipokine that regulates adipogenesis and adipocyte metabolism.J Biol Chem,2007,282:28175-28188.
  • 3Samson M,Ediger AL,Stordeur P,et al.ChemR23,a putative chemoattractant receptor,is expressed in monocyte-derived dendritic cells and macrophages and is a coreceptor for SIV and some primary HIV-1 strains.Eur J Immunol,1998,28:1689-1700.
  • 4Bozaoglu K,Bolto K,McMillan J,et al,Chemerin is a novel adipokine associated with obesity and metabolic syndrome.Endocrinology,2007,148:4687-4694.
  • 5Moretta A,Marcenaro E,Parolini S,et al.NK cells at the interface between innate and adaptive immunity.Cell Death Differ,2008,15:226-233.
  • 6Yoshimura T,Oppenheim JJ.Chemerin reveals its chimeric nature.J Exp Med,2008,205:2187-2190.
  • 7Almeda-Valdes P,Cuevas-Ramos D,Aguilar-Salinas CA.Metabolic syndrome and non-alcoholic fatty liver disease.Ann Hepatol,2009,8 (Suppl 1):S18-S24.
  • 8Anstee QM,Coldin RD.Mouse models in non-alcoholic fatty liver disease and steatohepatitis research.Int J Exp Pathol,2006,87:1-16.
  • 9Rinella ME,Green RM.The methionine-choline eficient dietary model of steatohepatitis does not exhibit insulin resistance.J Hepatol,2004,40:47-51.
  • 10Briadledy DN,Wang CN,Mei J,et al.Tumor necrosis factor-alpha and ceramides in insulin resistance.Lipids,1999,34 Suppl:S85-S88.

同被引文献14

  • 1陈存仁,栗夏莲.罗格列酮和白细胞介素-6对3T3-L1脂肪细胞chemerin mRNA表达的影响[J].中国实用医刊,2010,37(1):42-44. 被引量:1
  • 2王战建,张耀,苏杰英,庞建华,宋庆芳,王振贤,徐焕宇.TNF-α在饮食诱导糖尿病大鼠肝脏的表达及罗格列酮的干预研究[J].河北医药,2007,29(1):33-35. 被引量:5
  • 3Bozaoglu K, Bolton K, McMillan J,et al.Chemerin is a novel adipo- kine associated with obesity and metabolic syndrome[J]. Endocrinol- ogy, 2007, 148( 10): 4687-4694.
  • 4Goralski KB, McCarthy TC, Hanniman EA, et al.Chemerin, a novel adipokine that regulates adipogenesis and adipocyte metabolism[J]. J Biol Chem, 2007, 282(38): 28175-28188.
  • 5Rob SG, Song SH, Choi KC,et al.Chemerin-a new adipokine that modulates adipogenesis via its own receptor[J]. Biochem Biophys Res Commun, 2007, 362(4): 1013-1018.
  • 6Parlee SD, Ernst MC, Muruganandan S, et al.Serum chemerin levels vary with time of day and are modified by obesity and tumor necro- sis factor-{alpha}[J]. Endocrinology, 2010,151(6): 2590-2602.
  • 7Catalan V, Gomez-Ambrosi J, Rodriguez A, et al.Increased levels of chemerin and its receptor, chemokine-like receptor-l, in obesity are related to inflammation: tumor necrosis factor-alpha stimulates mRNA levels of chemerin in visceral adipocytes from obese patients [J]. Surg Obes Relat Dis, 2011 Nov 10. [Epub ahead of print].
  • 8Schmittgen TD, Livak KJ. Analyzing real-time PCR data by the comparative C(T) method[J]. Nat Protoc, 2008,3 (6): 1101-1108.
  • 9Takahashi M, Takahashi Y, Takahashi K, et al.Chemerin enhances insulin signaling and potentiates insulin-stimulated glucose uptake in 3T3-L1 adipocytes[J]. FEBS Lett, 2008,582(5): 573-578.
  • 10Becker M, Rabe K, Lebherz C, et al.Expression of human chemerin induces insulin resistance in the skeletal muscle but does not affect weight, lipid levels, and atherosclerosis in LDL receptor knockout mice on high-fat diet[J]. Diabetes, 2010,59( 11 ): 2898-2903.

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部